India’s COVID-19 emergency.
the two-pronged strategy strategy suggested to fix this problem overlooked a crucial aspect: the widespread corruption that has plagued the Indian health-care system for a long time.
From the beginning of the pandemic, the Indian Council of Medical Research (ICMR), an apex body responsible for the handling of the COVID-19 pandemic, approached the pandemic with a method of non-transparency, and some of the therapies it promoted appeared to be influenced more by political reasons than scientific evidence.
- Fiolet T
- Guihur A
- Rebeaud ME
- et al.
the Indian National Task Force of the ICMR issued clinical guidance on April 22, 2021, recommending that doctors in India use hydroxychloroquine for the treatment of home-bound patients with COVID-19.
Clinical guidance for management of adult COVID-19 patients.
It is questionable why Indian authorities have continued to promote the use of hydroxychloroquine in combating COVID-19 while ignoring overwhelming medical evidence against it.
Even the Indian Medical Association, usually a close ally of the Indian Health Ministry, had to criticise such reckless promotion of a questionable therapy by the health minister.
There is no doubt that India urgently needs to change its course to curb the ongoing rampage by the second wave of infections by boosting the existing vaccination policy in a transparent manner and implementing meaningful measures to minimise virus transmission. Unfortunately, these crucial changes to save tens of thousands of Indians are not likely to happen until the deep-rooted corruption in the Indian medical system is eradicated.

Supplementary Material
References
- 1.
India’s COVID-19 emergency.
Lancet. 2021; 3971683
- 2.
Tackling corruption in Indian medicine.
Lancet. 2013; 382: e23-e24
- 3.
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systemic review and meta-analysis.
Clin Micro Infect. 2021; 27: 19-27
- 4.
Clinical guidance for management of adult COVID-19 patients.
- 5.
Coronavirus: the misleading claims about an Indian remedy.
Article Info
Publication History
Identification
DOI: https://doi.org/10.1016/S0140-6736(21)01227-7
Copyright
© 2021 Elsevier Ltd. All rights reserved.
ScienceDirect
Access this article on ScienceDirect
Linked Articles
- India’s COVID-19 emergency
-
The scenes of suffering in India are hard to comprehend. As of May 4, more than 20·2 million cases of COVID-19 had been reported, with a rolling average of 378 000 cases a day, together with more than 222 000 deaths, which experts believe are likely to be substantial underestimates. Hospitals are overwhelmed, and health workers are exhausted and becoming infected. Social media is full of desperate people (doctors and the public) seeking medical oxygen, hospital beds, and other necessities. Yet before the second wave of cases of COVID-19 began to mount in early March, Indian Minister of Health Harsh Vardhan declared that India was in the “endgame” of the epidemic.
- Full-Text
-

